PubMed:18818423
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 976-985 | https://glytoucan.org/Structures/Glycans/G71832QJ | denotes | A antigen |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 976-985 | Glycan_Motif | denotes | A antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G71832QJ |
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 42-46 | DiseaseOrPhenotypicFeature | denotes | SARS | 0005091 |
| T2 | 129-162 | DiseaseOrPhenotypicFeature | denotes | Severe acute respiratory syndrome | 0005091 |
| T3 | 176-180 | DiseaseOrPhenotypicFeature | denotes | SARS | 0005091 |
| T4 | 255-258 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
| T5 | 324-328 | DiseaseOrPhenotypicFeature | denotes | SARS | 0005091 |
| T6 | 552-561 | DiseaseOrPhenotypicFeature | denotes | infection | 0005550 |
| T7 | 1476-1480 | DiseaseOrPhenotypicFeature | denotes | SARS | 0005091 |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 976-985 | https://glytoucan.org/Structures/Glycans/G71832QJ | denotes | A antigen |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-128 | Sentence | denotes | Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. |
| TextSentencer_T2 | 129-298 | Sentence | denotes | Severe acute respiratory syndrome coronavirus (SARS-CoV) is a highly pathogenic emergent virus which replicates in cells that can express ABH histo-blood group antigens. |
| TextSentencer_T3 | 299-428 | Sentence | denotes | The heavily glycosylated SARS-CoV spike (S) protein binds to angiotensin-converting enzyme 2 which serves as a cellular receptor. |
| TextSentencer_T4 | 429-562 | Sentence | denotes | Epidemiological analysis of a hospital outbreak in Hong Kong revealed that blood group O was associated with a low risk of infection. |
| TextSentencer_T5 | 563-749 | Sentence | denotes | In this study, we used a cellular model of adhesion to investigate whether natural antibodies of the ABO system could block the S protein and angiotensin-converting enzyme 2 interaction. |
| TextSentencer_T6 | 750-1006 | Sentence | denotes | To this aim, a C-terminally EGFP-tagged S protein was expressed in chinese hamster ovary cells cotransfected with an alpha1,2-fucosyltransferase and an A-transferase in order to coexpress the S glycoprotein ectodomain and the A antigen at the cell surface. |
| TextSentencer_T7 | 1007-1373 | Sentence | denotes | We observed that the S protein/angiotensin-converting enzyme 2-dependent adhesion of these cells to an angiotensin-converting enzyme 2 expressing cell line was specifically inhibited by either a monoclonal or human natural anti-A antibodies, indicating that these antibodies may block the interaction between the virus and its receptor, thereby providing protection. |
| TextSentencer_T8 | 1374-1619 | Sentence | denotes | In order to more fully appreciate the potential effect of the ABO polymorphism on the epidemiology of SARS, we built a mathematical model of the virus transmission dynamics that takes into account the protective effect of ABO natural antibodies. |
| TextSentencer_T9 | 1620-1814 | Sentence | denotes | The model indicated that the ABO polymorphism could contribute to substantially reduce the virus transmission, affecting both the number of infected individuals and the kinetics of the epidemic. |
| T1 | 0-128 | Sentence | denotes | Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. |
| T2 | 129-298 | Sentence | denotes | Severe acute respiratory syndrome coronavirus (SARS-CoV) is a highly pathogenic emergent virus which replicates in cells that can express ABH histo-blood group antigens. |
| T3 | 299-428 | Sentence | denotes | The heavily glycosylated SARS-CoV spike (S) protein binds to angiotensin-converting enzyme 2 which serves as a cellular receptor. |
| T4 | 429-562 | Sentence | denotes | Epidemiological analysis of a hospital outbreak in Hong Kong revealed that blood group O was associated with a low risk of infection. |
| T5 | 563-749 | Sentence | denotes | In this study, we used a cellular model of adhesion to investigate whether natural antibodies of the ABO system could block the S protein and angiotensin-converting enzyme 2 interaction. |
| T6 | 750-1006 | Sentence | denotes | To this aim, a C-terminally EGFP-tagged S protein was expressed in chinese hamster ovary cells cotransfected with an alpha1,2-fucosyltransferase and an A-transferase in order to coexpress the S glycoprotein ectodomain and the A antigen at the cell surface. |
| T7 | 1007-1373 | Sentence | denotes | We observed that the S protein/angiotensin-converting enzyme 2-dependent adhesion of these cells to an angiotensin-converting enzyme 2 expressing cell line was specifically inhibited by either a monoclonal or human natural anti-A antibodies, indicating that these antibodies may block the interaction between the virus and its receptor, thereby providing protection. |
| T8 | 1374-1619 | Sentence | denotes | In order to more fully appreciate the potential effect of the ABO polymorphism on the epidemiology of SARS, we built a mathematical model of the virus transmission dynamics that takes into account the protective effect of ABO natural antibodies. |
| T9 | 1620-1814 | Sentence | denotes | The model indicated that the ABO polymorphism could contribute to substantially reduce the virus transmission, affecting both the number of infected individuals and the kinetics of the epidemic. |
| T1 | 0-128 | Sentence | denotes | Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. |
| T2 | 129-298 | Sentence | denotes | Severe acute respiratory syndrome coronavirus (SARS-CoV) is a highly pathogenic emergent virus which replicates in cells that can express ABH histo-blood group antigens. |
| T3 | 299-428 | Sentence | denotes | The heavily glycosylated SARS-CoV spike (S) protein binds to angiotensin-converting enzyme 2 which serves as a cellular receptor. |
| T4 | 429-562 | Sentence | denotes | Epidemiological analysis of a hospital outbreak in Hong Kong revealed that blood group O was associated with a low risk of infection. |
| T5 | 563-749 | Sentence | denotes | In this study, we used a cellular model of adhesion to investigate whether natural antibodies of the ABO system could block the S protein and angiotensin-converting enzyme 2 interaction. |
| T6 | 750-1006 | Sentence | denotes | To this aim, a C-terminally EGFP-tagged S protein was expressed in chinese hamster ovary cells cotransfected with an alpha1,2-fucosyltransferase and an A-transferase in order to coexpress the S glycoprotein ectodomain and the A antigen at the cell surface. |
| T7 | 1007-1373 | Sentence | denotes | We observed that the S protein/angiotensin-converting enzyme 2-dependent adhesion of these cells to an angiotensin-converting enzyme 2 expressing cell line was specifically inhibited by either a monoclonal or human natural anti-A antibodies, indicating that these antibodies may block the interaction between the virus and its receptor, thereby providing protection. |
| T8 | 1374-1619 | Sentence | denotes | In order to more fully appreciate the potential effect of the ABO polymorphism on the epidemiology of SARS, we built a mathematical model of the virus transmission dynamics that takes into account the protective effect of ABO natural antibodies. |
| T9 | 1620-1814 | Sentence | denotes | The model indicated that the ABO polymorphism could contribute to substantially reduce the virus transmission, affecting both the number of infected individuals and the kinetics of the epidemic. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 105-110 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T2 | 105-110 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T3 | 277-282 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T4 | 277-282 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T5 | 504-509 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T6 | 504-509 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T32 | 1237-1247 | FMAID:167180 | denotes | antibodies |
| _T1 | 57-64 | FMAID:165447 | denotes | protein |
| _T2 | 57-64 | FMAID:67257 | denotes | protein |
| _T3 | 105-110 | FMAID:256053 | denotes | blood |
| _T4 | 117-127 | FMAID:167180 | denotes | antibodies |
| _T5 | 241-249 | FMAID:199054 | denotes | in cells |
| _T6 | 241-249 | FMAID:84785 | denotes | in cells |
| _T7 | 244-249 | FMAID:68646 | denotes | cells |
| _T8 | 244-249 | FMAID:169002 | denotes | cells |
| _T9 | 277-282 | FMAID:256053 | denotes | blood |
| _T10 | 343-350 | FMAID:165447 | denotes | protein |
| _T11 | 343-350 | FMAID:67257 | denotes | protein |
| _T12 | 504-509 | FMAID:256053 | denotes | blood |
| _T13 | 646-656 | FMAID:167180 | denotes | antibodies |
| _T14 | 693-700 | FMAID:165447 | denotes | protein |
| _T15 | 693-700 | FMAID:67257 | denotes | protein |
| _T16 | 792-799 | FMAID:67257 | denotes | protein |
| _T17 | 792-799 | FMAID:165447 | denotes | protein |
| _T18 | 833-838 | FMAID:7209 | denotes | ovary |
| _T19 | 833-838 | FMAID:93687 | denotes | ovary |
| _T20 | 839-844 | FMAID:169002 | denotes | cells |
| _T21 | 839-844 | FMAID:68646 | denotes | cells |
| _T22 | 944-956 | FMAID:167256 | denotes | glycoprotein |
| _T23 | 944-956 | FMAID:62925 | denotes | glycoprotein |
| _T24 | 993-1005 | FMAID:200942 | denotes | cell surface |
| _T25 | 993-1005 | FMAID:212684 | denotes | cell surface |
| _T26 | 998-1005 | FMAID:146300 | denotes | surface |
| _T27 | 998-1005 | FMAID:50594 | denotes | surface |
| _T28 | 1030-1037 | FMAID:67257 | denotes | protein |
| _T29 | 1030-1037 | FMAID:165447 | denotes | protein |
| _T30 | 1098-1103 | FMAID:68646 | denotes | cells |
| _T31 | 1098-1103 | FMAID:169002 | denotes | cells |
| _T33 | 1271-1281 | FMAID:167180 | denotes | antibodies |
| _T34 | 1608-1618 | FMAID:167180 | denotes | antibodies |
| _T35 | 1686-1699 | FMAID:188924 | denotes | substantially |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 42-46 | http://www.uniprot.org/uniprot/P49591 | denotes | SARS |
| T2 | 176-180 | http://www.uniprot.org/uniprot/P49591 | denotes | SARS |
| T3 | 324-328 | http://www.uniprot.org/uniprot/P49591 | denotes | SARS |
| T4 | 1476-1480 | http://www.uniprot.org/uniprot/P49591 | denotes | SARS |
| T5 | 267-270 | http://www.uniprot.org/uniprot/Q13686 | denotes | ABH |
| T6 | 277-297 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | blood group antigens |
| T7 | 277-297 | http://www.uniprot.org/uniprot/B2RUZ4 | denotes | blood group antigens |
| T8 | 277-297 | http://www.uniprot.org/uniprot/O75326 | denotes | blood group antigens |
| T9 | 277-297 | http://www.uniprot.org/uniprot/P35613 | denotes | blood group antigens |
| T10 | 340-350 | http://www.uniprot.org/uniprot/P04004 | denotes | S) protein |
| T11 | 360-389 | http://www.uniprot.org/uniprot/Q9BYF1 | denotes | angiotensin-converting enzyme |
| T12 | 705-734 | http://www.uniprot.org/uniprot/Q9BYF1 | denotes | angiotensin-converting enzyme |
| T13 | 360-391 | http://www.uniprot.org/uniprot/Q9BYF1 | denotes | angiotensin-converting enzyme 2 |
| T14 | 705-736 | http://www.uniprot.org/uniprot/Q9BYF1 | denotes | angiotensin-converting enzyme 2 |
| T15 | 1038-1069 | http://www.uniprot.org/uniprot/Q9BYF1 | denotes | angiotensin-converting enzyme 2 |
| T16 | 1110-1141 | http://www.uniprot.org/uniprot/Q9BYF1 | denotes | angiotensin-converting enzyme 2 |
| T17 | 360-389 | http://www.uniprot.org/uniprot/P12821 | denotes | angiotensin-converting enzyme |
| T18 | 705-734 | http://www.uniprot.org/uniprot/P12821 | denotes | angiotensin-converting enzyme |
| T19 | 1038-1067 | http://www.uniprot.org/uniprot/P12821 | denotes | angiotensin-converting enzyme |
| T20 | 1110-1139 | http://www.uniprot.org/uniprot/P12821 | denotes | angiotensin-converting enzyme |
| T21 | 664-667 | http://www.uniprot.org/uniprot/Q99484 | denotes | ABO |
| T22 | 1436-1439 | http://www.uniprot.org/uniprot/Q99484 | denotes | ABO |
| T23 | 1596-1599 | http://www.uniprot.org/uniprot/Q99484 | denotes | ABO |
| T24 | 904-915 | http://www.uniprot.org/uniprot/Q99484 | denotes | transferase |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 340-350 | http://www.uniprot.org/uniprot/P29788 | denotes | S) protein |
| T2 | 360-389 | http://www.uniprot.org/uniprot/P09470 | denotes | angiotensin-converting enzyme |
| T3 | 705-734 | http://www.uniprot.org/uniprot/P09470 | denotes | angiotensin-converting enzyme |
| T4 | 1038-1067 | http://www.uniprot.org/uniprot/P09470 | denotes | angiotensin-converting enzyme |
| T5 | 1110-1139 | http://www.uniprot.org/uniprot/P09470 | denotes | angiotensin-converting enzyme |
| T6 | 360-391 | http://www.uniprot.org/uniprot/Q8R0I0 | denotes | angiotensin-converting enzyme 2 |
| T7 | 705-736 | http://www.uniprot.org/uniprot/Q8R0I0 | denotes | angiotensin-converting enzyme 2 |
| T8 | 1038-1069 | http://www.uniprot.org/uniprot/Q8R0I0 | denotes | angiotensin-converting enzyme 2 |
| T9 | 1110-1141 | http://www.uniprot.org/uniprot/Q8R0I0 | denotes | angiotensin-converting enzyme 2 |
| T10 | 904-915 | http://www.uniprot.org/uniprot/P38649 | denotes | transferase |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 111-116 | http://purl.bioontology.org/ontology/STY/T096 | denotes | group |
| T2 | 129-174 | http://purl.bioontology.org/ontology/NCBITAXON/694009 | denotes | Severe acute respiratory syndrome coronavirus |
| T3 | 218-223 | http://purl.bioontology.org/ontology/NCBITAXON/184751 | denotes | virus |
| T4 | 244-249 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T5 | 283-288 | http://purl.bioontology.org/ontology/STY/T096 | denotes | group |
| T6 | 510-515 | http://purl.bioontology.org/ontology/STY/T096 | denotes | group |
| T7 | 839-844 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T8 | 1098-1103 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T9 | 1202-1212 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
| T10 | 1320-1325 | http://purl.bioontology.org/ontology/NCBITAXON/184751 | denotes | virus |
| T11 | 1440-1452 | http://purl.bioontology.org/ontology/NCBITAXON/60540 | denotes | polymorphism |
| T12 | 1440-1452 | http://purl.bioontology.org/ontology/NCBITAXON/991903 | denotes | polymorphism |
| T13 | 1519-1524 | http://purl.bioontology.org/ontology/NCBITAXON/184751 | denotes | virus |
| T14 | 1653-1665 | http://purl.bioontology.org/ontology/NCBITAXON/991903 | denotes | polymorphism |
| T15 | 1653-1665 | http://purl.bioontology.org/ontology/NCBITAXON/60540 | denotes | polymorphism |
| T16 | 1711-1716 | http://purl.bioontology.org/ontology/NCBITAXON/184751 | denotes | virus |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 73-81 | http://purl.obolibrary.org/obo/GO_0007349 | denotes | cellular |
| T2 | 410-418 | http://purl.obolibrary.org/obo/GO_0007349 | denotes | cellular |
| T3 | 588-596 | http://purl.obolibrary.org/obo/GO_0007349 | denotes | cellular |
| T4 | 311-323 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T5 | 1080-1103 | http://purl.obolibrary.org/obo/GO_0007155 | denotes | adhesion of these cells |
| T6 | 1519-1537 | http://purl.obolibrary.org/obo/GO_0019089 | denotes | virus transmission |
| T7 | 1711-1729 | http://purl.obolibrary.org/obo/GO_0019089 | denotes | virus transmission |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 117-127 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T2 | 646-656 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T3 | 1237-1247 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T4 | 1271-1281 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T5 | 1608-1618 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T6 | 343-356 | http://purl.obolibrary.org/obo/GO_0005515 | denotes | protein binds |
| T7 | 351-356 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binds |
| T8 | 351-356 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binds |
| T9 | 351-356 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binds |
| T10 | 351-356 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binds |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 244-249 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T2 | 839-844 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T3 | 993-997 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T4 | 1153-1157 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T5 | 993-1005 | http://purl.obolibrary.org/obo/GO_0009986 | denotes | cell surface |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 105-110 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T2 | 277-282 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T3 | 504-509 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
GlycoBiology-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 105-110 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T2 | 105-110 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T3 | 277-282 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T4 | 277-282 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T5 | 504-509 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T6 | 504-509 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 105-116 | http://rdf.glycoinfo.org/glycan/G00066MO | denotes | blood group |
| T2 | 277-288 | http://rdf.glycoinfo.org/glycan/G00066MO | denotes | blood group |
| T3 | 504-515 | http://rdf.glycoinfo.org/glycan/G00066MO | denotes | blood group |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 105-110 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| PD-UBERON-AE-B_T2 | 277-282 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| PD-UBERON-AE-B_T3 | 504-509 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 105-110 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T3 | 277-282 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T5 | 504-509 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 42-50 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T2 | 129-162 | Disease | denotes | Severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T3 | 176-184 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T4 | 324-332 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T5 | 552-561 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T6 | 1476-1480 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 42-50 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T2 | 129-162 | OrganismTaxon | denotes | Severe acute respiratory syndrome | 694009 |
| T3 | 176-184 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T4 | 324-332 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T5 | 817-832 | OrganismTaxon | denotes | chinese hamster | 10029 |
| T6 | 1216-1221 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 105-110 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T2 | 277-282 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T3 | 504-509 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T4 | 833-838 | Body_part | denotes | ovary | http://purl.obolibrary.org/obo/UBERON_0000992 |